aripiprazole has been researched along with flb 457 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CM; Frankle, WG; Himes, M; Keating, P; Laruelle, M; Mason, NS; Mathis, CA; May, MA; Narendran, R; Rabiner, EA | 1 |
| Arakawa, R; Fujiwara, H; Ito, H; Kato, M; Kimura, Y; Kodaka, F; Mimura, M; Nagashima, T; Nogami, T; Sasaki, T; Shimada, H; Suhara, T; Suzuki, M; Takahata, K; Takano, H | 1 |
2 trial(s) available for aripiprazole and flb 457
| Article | Year |
|---|---|
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Carbon Radioisotopes; Cerebellum; Cerebral Cortex; Dopamine; Female; Humans; Male; Piperazines; Positron-Emission Tomography; Pyrrolidines; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Young Adult | 2011 |
Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain; Carbon Radioisotopes; Corpus Striatum; Humans; Male; Piperazines; Positron-Emission Tomography; Pyrrolidines; Quinolones; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Salicylamides; Young Adult | 2012 |